This site is intended for healthcare professionals

Are COVID-19 vaccines effective against long Covid?

Time : 8th of December 2022 11:40:20 AM Physician/Medicine,Pharma News,Covid-19

A meta-analysis revealed that one or more doses of COVID-19 vaccines are 29% effective in preventing symptoms that last for three weeks or more after infection. People who received the vaccine after infection also experienced some benefits. These findings might encourage and reassure unvaccinated people with persistent symptoms to get vaccinated.

Rebound of COVID-19 after Paxlovid treatment is rare

Time : 7th of December 2022 01:05:16 PM Physician/Medicine,Pharma News,Covid-19

A study from Hong Kong on hospitalized patients with COVID-19 revealed the rebound of the virus infection after treatment with Paxlovid ( nirmatrelvir-ritonavir) and molnupiravir was uncommon. It also showed these treatments were not associated with higher chances of mortality. These findings suggest using these treatments for treating patients with early COVID-19 infection.

COVID-19 may not increase type 1 diabetes risk in children

Time : 6th of December 2022 11:09:11 AM Paediatrics,Endocrinology & Diabetes,Covid-19

A study conducted on children in Denmark did not find a higher risk of first-time diagnoses of type 1 diabetes in kids 30 days or more following a positive COVID-19 test compared to that in kids without a history of COVID-19. These findings suggest that a special focus on type 1 diabetes after COVID-19 infection in children might not be required.
  Twitter @TracyBethHoeg

FDA retrieves authorization for Eli Lily's COVID-19 drug bebtelovimab

Time : 5th of December 2022 10:36:45 AM Physician/Medicine,Pharma News,Covid-19

The antibody therapy is not expected to work against Omicron subvariants BQ.1 and BQ.1.1. The firm has already paused the distribution of the drug. The FDA suggested that physicians use other drugs that are expected to work against these subvariants, including Paxlovid, Veklury, and Lagevrio. High titers of convalescent plasma is also advised for people with immune diseases.

Surgical masks non-inferior to N95 masks for preventing COVID-19 spread

Time : 30th of November 2022 10:49:25 AM Physician/Medicine,Nursing,Covid-19

A study on healthcare providers who were routinely caring for COVID-19 patients or people suspected to have COVID-19 revealed that the risk of testing positive for COVID-19 did not differ much among healthcare workers using medical masks or N95 respirator masks. The study was conducted on over 1000 healthcare workers from Canada, Israel, Egypt, and Pakistan.

BQ.1.1 variant of COVID-19 virus is resistant to all antibody therapies

Time : 24th of November 2022 12:59:36 PM Physician/Medicine,Pharma News,Covid-19

A study revealed that none of the monoclonal antibodies and antibody cocktails neutralized the new Omicron subvariant, which has become dominant in the US. These findings suggest that patients infected with BQ.1.1 should be recommended additional therapies like Paxlovid or molnupiravir. Also, COVID-19 prophylaxis with monoclonal antibodies could help people at high risk.
  Medical Republic

WHO warns about the impending global threat of measles outbreaks

Time : 24th of November 2022 12:19:49 PM Physician/Medicine,Paediatrics,Nursing,Covid-19

The COVID-19 pandemic caused a decline in immunization against measles and disruptions in the surveillance of infections worldwide. About 40 million children missed their measles vaccines in 2021. WHO reported large outbreaks at the beginning of 2022, especially in sub-Saharan Africa. WHO's measles head said the coming 12 to 24 months could be challenging.
  Twitter @Reuters_Health

Switzerland to discard 9 million expired Moderna vaccines

Time : 21st of November 2022 12:42:21 PM Pharma News,Covid-19

An additional 5.1 million COVID-19 shots are expected to get discarded by February, as per reports. This wastage reflects the nation's strategy of ensuring sufficient vaccine supplies to its population of 8.7 million. Several other countries have also discarded millions of expired vaccines. Less than 70% of Switzerland's population is vaccinated with at least one dose.
  Twitter @Reuters_Health

Teachers more depressed and anxious than any other workers during the pandemic

Time : 18th of November 2022 01:11:10 PM Psychiatry & Mental Health,Covid-19

People working as teachers reported more negative mental health outcomes than those working in healthcare or offices. Healthcare workers, office workers, and other workers were less likely to report anxiety than teachers. Also, healthcare workers were at a lower risk of being depressed than teachers. But office workers and other workers were more likely to feel isolated.

Seizures more likely after COVID-19 than post-influenza

Time : 18th of November 2022 12:47:38 PM Pulmonology,Neurology & Neurosurgery,Covid-19

People who had COVID-19 had a 55% higher risk of developing seizures or epilepsy six months after the infection compared to those who had flu, according to a study. The rate of seizures in COVID-19 patients was 0.94% compared to 0.6% in people with flu. The risk was more significant in kids than in adults, suggesting that epilepsy cases may increase significantly.
  Neuroscience News